Media

Filter by Category

All Blog News Podcasts Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

January 22, 2024

C-Path’s TRxA Announces its 2024 Global Request for Proposals from Academic Investigators Working to Advance Drug Development Projects

Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) today announced...

January 9, 2024

Longtime quantitative medicine and regulatory science expert to spearhead C-Path's collaborative efforts in accelerating...

November 9, 2023

TUCSON, Ariz., Nov. 9, 2023 – Critical Path Institute (C-Path) is pleased to announce the release of a new peer-reviewed publica

November 30, 2023

C-Path’s 2023 Neuroscience Program Annual Meeting is set for Thursday, November 30 in Washington D.C. Bringing stakeholders....

Critical Path for Parkinson’s mission is to serve as a leading international consortium convening diverse stakeholders to

October 16, 2023

Neurological disorders represent some of the most challenging therapeutic areas for successful drug approvals.

The Critical Path for Parkinson’s Consortium is excited to welcome Biohaven as its newest member. Biohaven is a biopha

AcureX is a pharmaceutical company on a mission to stop major neurodegenerative diseases before they start, with an

July 18, 2023

AMSTERDAM and TUCSON, Ariz., July 18, 2023 — Critical Path Institute (C-Path) announced today the completion of the integration

July 6, 2023

TUCSON, Ariz., July 6, 2023 — Critical Path Institute (C-Path) and the Center for Health + Technology (CHeT) at University of Ro